GSK Plc (GSK)

48.60 +0.53 (+1.10%) USD  |  NYSE  |  Jan 22, 15:01
More

GSK Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for GSK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
AstraZeneca PLC --
Biodexa Pharmaceuticals Plc --
AnaptysBio, Inc. Upgrade
NuCana Plc Upgrade
Mereo BioPharma Group Plc Upgrade